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Charybdotoxin, a short scorpion venom neurotoxin, which was thought to be specific for the blockade of Ca*+-activated 
Kf channels also blocks a class of voltage-sensitive K+channels that are known to be the target of other peptide neurotox- 
ins from snake and bee venoms such as dendrotoxin and MCD peptide. Charybdotoxin also inhibits ‘%dendrotoxin 
and ‘ZsI-MCD peptide binding to their receptors. All these effects are observed with an IC,, of about 30 nM. 
K+ channel; Charybdotoxin; Dendrotoxin; Mast cell degranulating peptide; (Dorsal root ganglia, Rat brain) 
1. INTRODUCTION 
Charybdotoxin (ChTX) is a small neurotoxin 
from the venom of the scorpion Leiurus quin- 
questriatus hebraeus [l-4]. It has been described 
as a potent blocker of high conductance K+-speci- 
fit channels which are activated by both intra- 
cellular Ca2+ and membrane potential variations 
[l]. The affinity of ChTX for the large conduc- 
tance (200 pS) channel is in the nanomolar to 
10 nM range [2,3]. ChTX has also been shown to 
block a lower conductance (30 pS) Ca2+-activated 
K+ channel in molluscan neurons [4]. In this 
preparation it is without effect on other types of 
IQ channels. Other K+ channels are blocked by 
other types of polypeptide toxins [5-71. Den- 
drotoxins from snake venoms, and particularly 
dendrotoxin I, the most potent representative in 
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this series, are high-affinity blockers of voltage- 
sensitive K+ channels [8- 111. Dendrotoxin- 
sensitive voltage-activated K+ channels have a con- 
ductance of 5-10 pS and they appear to be insen- 
sitive to intracellular Ca2’ [ 111. This type of 
channel is also blocked by the bee venom peptide 
toxin, the mast cell degranulating peptide (MCD) 
t121. 
This report shows that ChTX is not selective for 
Ca2+-dependent K+ channels. It also blocks 
dendrotoxin-sensitive voltage-activated K+ chan- 
nels. 
2. MATERIALS AND METHODS 
2.1. Purification of Ch TX 
The venom of the scorpion Leiutus quinquestriatus hebraeus 
was obtained from Latoxan (France). The purification pro- 
cedure included the following steps: a filtration on Sephadex 
GSO, a succession of HPLC steps on the ion-exchange column 
TSK SP 5PW, reverse-phase Cs, a second chromatography on 
TSK SP 5PW, another reverse-phase Cls, and finally desalting 
on Sephadex G25. The purity of the toxin was over 99%, 
estimated from the last HPLC on reverse-phase cls. Recovery 
was 0.17% of the dry venom. The purity of the toxin was also 
checked by the sequence determination which was found to be 
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identical to that previously reported [3]. The toxin was fully ac- 
tive on large Ca2+-activated K + channels. 
2.2. Short-term culture of  the rat dorsal root ganglion 
(DRG) cells 
DRG cells from 4-day-old rats were mechanically dissociated 
following enzyme treatment, collagenase (Sigma, 1 mg/ml) and 
dispase (Sigma, 5 mg/ml), and allowed to attach to collagen- 
coated culture dishes for 6 h in an LI5 medium containing 15% 
horse serum, as described by Bossu et al. [13]. Recordings were 
made between 6 and 14 h in culture. 
2.3. Electrophysiological measurements 
Electrophysiological studies have been performed on rat 
DRG cells using conventional patch-clamp recording methods 
with the use of a List EPC7 amplifier (Darmstadt, FRG). Cur- 
rents were recorded on a Racal taperecorder and subsequently 
filtered and digitized for analysis. The pipette filling solution 
contained 110 mM KC1, 20 mM KF, 10/zM A1C13, 1 mM 
EGTA, 2 mM MgC12, 10 mM Hepes-Tris, pH 7.2. External 
'physiological' K ÷ solution 5 mM Hepes-Tris, 10 mM glucose. 
For 'symmetrical' K + conditions the choline CI was replaced by 
KCI. 
2.4. Binding assays 
Synaptosomal P3membranes from rat brain were prepared as 
described [14]. Protein concentrations were determined ac- 
cording to Bradford [15] using bovine serum albumin as a stan- 
dard. The conditions of 12SI-MCD and 125I-DTXI binding to 
membranes was carried out as previously described [16], free 
and bound labelled toxins were separated by a rapid centrifuga- 
tion method as previously described [14]. Incubations were car- 
ried out at 4°C for 30 rain. The concentration of 12SI-labelled 
toxins was 20 pM, that of unlabelled toxins and membranes in
the binding experiments are indicated in the legends of the 
figures. Membrane pellets were counted in a -r-counter. All 
binding data were corrected for binding to tubes measured in 
the absence of membranes and for non-specific binding 
measured in the presence of 100 nM of the unlabelled toxin. 
Each data represented the mean value of duplicate deter- 
minations. 
3. RESULTS AND DISCUSSION 
Electrophysiological studies of the action of 
charybdotoxin on a known DTX-sensitive K ÷ cur- 
rent have been performed, using conventional 
patch-clamp recording methods [17] on rat dorsal 
root ganglion cells (DRG) in short-term culture. 
These cells have a large voltage-activated, non- 
Ca2+-activated K + current which is blocked by low 
nanomolar concentrations of DTX [8,11]. The cur- 
rent can be evoked by stepping the membrane 
voltage up to between -60  and 0 mV from a 
holding potential of around -90  mV. Further, 
with appropriate ionic conditions given in section 
2, channel activity can be restricted almost ex- 
elusively to this particular current. The current is 
equally well expressed in either the whole cell or in 
isolated outside-out patches of cell membrane con- 
taining multiple channels. Using both of these con- 
ditions, ChTX (10nM-1/zM) applied to five 
preparations (two whole cell, three outside out 
patches), induced a rapid (a few seconds) 
concentration-dependent r duction in current. An 
example of this current and its blockade by ChTX 
is seen in fig.1. Recovery was slow: 20 min for the 
partial recovery shown in fig. 1. 
A dose-response curve of the ChTX effect on the 
DTX-sensitive K ÷ current is presented in fig.2. The 
IC50 of the blockade was around 30 nM. 
Both DTXI and MCD receptors have been 
previously identified using their 125I-labelled 
derivatives [12,14]. t25I-DTXx and 12~I-MCD 
associate with high affinity (Ka = 41 pM and 
158 pM, respectively) totheir binding sites in brain 
synaptic membranes [16]. DTXI and MCD recep- 
tors are distinct and allosterically related [12]. 
However they are both situated within the same 
protein component [18-20] of 77 kDa. 
Fig.2 shows that ChTX inhibits, in exactly the 
same way, both t25I-DTXI and 125I-MCD binding 
to their respective receptors. The ICso for the in- 
hibitory effect of ChTX was 30 nM. Binding data 
and electrophysiological data are nearly superim- 
posable. 
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Fig.1. Blockade of K + currents by ChTX in cultured DRG cells 
recorded by patch-clamp methods. Records were made at 22°C. 
Toxin was applied by close perfusion. Averaged currents (n = 
14) recorded from a large outside-out patch containing 
approximately 60 channels, in response to depolarizing steps 
according to the protocol shown below the traces. The K ÷ 
gradient is 'physiological' (EK -100 mV). ChTX (600 nM) 
produced almost total blockade. Partial recovery at 20 min is 
shown. 
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Fig.2. Comparison of the inhibition by ChTX of “‘I-DTXr (0) 
and ‘251-MCD (0) binding to synaptosomal membranes from 
rat brain with the dose-response curve showing proportion of 
evoked current blockade by ChTX (A, A, 0). Synaptic 
membranes (180 pg of protein/ml or 40 fig of protein/ml) were 
incubated with ‘*‘I-MCD or with ‘?-DTXr, respectively. 
Diagram (in arbitrary unit) shows for both ‘Z51-labelled toxins 
the total binding (T), the non-specific binding (NS) obtained in 
the presence of 100 nM of the respective unlabelled toxin and 
the binding obtained in the presence of 1 hM ChTX. For the 
dose-response curve showing proportion of evoked current 
blockade by ChTX three symbols apply to three different types 
of preparations: whole-cell recording (A), isolated patches with 
either 60-80 channels approximately in ‘physiological’ K+ 
gradient (A), or with fewer channels in ‘symmetrical’ K+ 
gradient (0). 
In one relatively small patch (fig.3) the channel 
activity was studied using a ‘symmetrical’ 
(130 mM) K+ distribution (see section 2) allowing 
clearer resolution of individual channel openings 
(fig.3). Channel conductance for an inward cur- 
rent between - 85 and - 40 mV was around 35 pS, 
in agreement with that reported for DTX-sensitive 
channels under the same conditions 18,111. In the 
presence of the toxin the general characteristics of 
individual channel openings was not obviously dif- 
ferent from those in the control period. This is 
consistent with a reduction in the numbers of ac- 
tive channels and reminiscent also, using synap- 
tosomal membranes, of the earlier reported 
manner of blockade by DTX. 
Charybdotoxin is very widely used with the 
belief that it blocks Cazf-activated K+ channels of 
large conductance (200 pS) [4]. This paper shows 
that the pure toxin is also a potent blocker of one 
well-identified class of voltage-sensitive K+ chan- 
nels: those sensitive to dendrotoxin. However it 
may have a better affinity (about 1 order of 
magnitude) for Ca2+-activated K+ channels [2,3]. 
b. 
-87a 
Fig.3. The effect of ChTX (200 nM) on inward current evoked 
from an isolated patch in ‘symmetrical’ K+. Sampled at 8 kHz, 
filter: low pass, 2 kHz, 8 pole Bessel. No leak subtraction. 
Voltage protocol shown below traces. (a) Averaged currents, 
n = 62 for control and n = 30 in the presence of toxin. (b) 
Examples of individual current traces showing unitary current 
activity in some cases. 
The fact that a single toxin blocks both a class 
of voltage-sensitive K+ channels and a class of 
Ca*+-activated K+ channels strongly suggests that 
there are homologies between these 2 types of 
channels. This conclusion is supported by the 
observation that another, much less potent scor- 
pion toxin, noxiustoxin, which blocks voltage- 
sensitive K+ channels in squid giant axons with an 
ICSO above 1.5 PM [21] also blocks large conduc- 
tance Ca2+-activated K+ channels in skeletal mus- 
cle with an ICSO of 450 nM [22]. 
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